Sign Up to like & get
recommendations!
1
Published in 2019 at "Genetic testing and molecular biomarkers"
DOI: 10.1089/gtmb.2018.0193
Abstract: AIMS About 50% of melanomas have the BRAFV600E mutation. This mutation is an attractive therapeutic target. The aims of our study were to detect BRAFV600E mutations within circulating cell-free DNA in plasma ("liquid biopsy") by…
read more here.
Keywords:
melanoma;
detection brafv600e;
brafv600e mutation;
digital pcr ... See more keywords